Leaflet ALMAGEL A oral suspension


Indicated for: gastroesophageal reflux; acid dyspepsia

Route of administration: oral

Substance: magnesium hydroxide + aluminum hydroxide + benzocaine (mineral antacids + local anesthetic)

ATC: A02AD01 (Alimentary tract and metabolism | Antacids | Combinations and complexes of aluminium, calcium and magnesium compounds)

The combination of magnesium hydroxide, aluminum hydroxide, and benzocaine is used for the symptomatic treatment of heartburn and gastric discomfort. Magnesium hydroxide and aluminum hydroxide neutralize stomach acid, while benzocaine provides local anesthetic effects, reducing pain.

The medication is taken orally, as directed by a doctor or the product leaflet, usually after meals or as needed.

Side effects may include constipation, diarrhea, nausea, or allergic reactions. In rare cases, prolonged use may lead to electrolyte imbalances.

This combination is not recommended for patients with severe renal impairment or hypersensitivity to any of the components.

General data about ALMAGEL A

  • Substance: magnesium hydroxide + aluminum hydroxide + benzocaine
  • Date of last drug list: 01-07-2013
  • Commercial code: W01470001
  • Pharmaceutical form: oral suspension
  • Quantity: 1
  • Product type: generic
  • Prescription restrictions: OTC - Over the Counter = medicines that do not require a prescription.

Marketing authorisation

  • Manufacturer: BALKAN PHARMA TROYAN AD - BULGARIA
  • Holder: BALKAN PHARMA TROYAN AD - BULGARIA
  • Number: 4084/2003/02
  • Shelf life: 2 years